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ABSTRACT 
Engineered Plasmonic Nanostructures for Nanomedicine Imaging, Sensing, and Therapy 
Applications 
By Christopher Matthew Portz 
Master of Science in Mechanical Engineering 
Washington University in St. Louis, 2014 
Research Advisor:  Dr. Srikanth Singamaneni 
 
Metal nanostructures are emerging as an important class of materials for nanomedicine due to the 
unique combination of physical, chemical, and biological properties such as large absorption and 
scattering cross-section, high sensitivity to local dielectric environment, and enhanced electric field at 
the surface.   High sensitivity of plasmonic nanostructures and their assemblies to the changes in the 
refractive index of the surrounding medium allows them to serve as a sensitive nanotransducer for 
the detection of chemical and biochemical analytes., These nanostructures also serve as 
‘nanoheaters’ for photothermal therapy due to the large absorption cross-section. Yet another 
important manifestation of enhanced electric field at the surface of plasmonic nanostructures is 
surface enhanced Raman scattering (SERS), which involves the dramatic enhancement of Raman 
scattering from molecules adsorbed on or in close proximity to nanostructured metal surface.  SERS 
has garnered much attention owing to its potential applications in chemical and biological sensing, 
environmental monitoring, and bioimaging.   SERS is particularly attractive in molecular bioimaging 
owing to its (i) large multiplexing ability; (ii) excellent photostability compared to organic dyes; (iii) 
absence of interference from water (iv) high spatial resolution; and (v) use of bio inert materials such 
as gold.  However, SERS based bioimaging remains a challenge due primarily to the lack of bright, 
easy-to-synthesize, stable and reproducible SERS probes. 
  
Except for a few reports, most of the current SERS probe (i.e., contrast agents) designs so far 
involve individual plasmonic nanostructures uniformly appended with Raman reporters, which offer 
limited SERS enhancement and suffer from poor stability due to desorption or enzymatic 
degradation of the Raman reporters in physiological environment.  In this context, we designed and 
developed a novel SERS probe design, which involves trapping Raman reporter molecules between 
two concentric nanostructured gold layers (i.e., gold core and shell). The novel SERS probe  
demonstrated here offers nearly 20 times brighter SERS intensity compared to existing SERS tags 
 
 
viii 
based on individual gold nanostructures.   Furthermore, so far most of the efforts have been limited 
to design and optimization of the plasmonic nanostructures to perform either imaging or targeted 
delivery.   In this study, we explored two designs of an all-in-one plasmonic nanostructure, which 
can be tracked non-invasively using NIR light, externally triggered to release the drug and non-
invasively monitor the cargo level in the carriers at different stages. The first design involved Janus 
nanostructures that are comprised of hollow (drug carrier) and solid (SERS tag) parts, which renders 
multifunctionality to the envisioned nanostructures.  We choose SERS tags as optical label owing to 
their ultra-bright nature, large multiplexing ability, and more importantly, their photostability.    A 
second design involved plasmonic nanorattles comprised of a bright SERS probe trapped in a 
porous gold shell.  The SERS signal from nanorattles, comprised of two Raman reporters, was 
designed to report the state of the plasmonic nanostructure. 
 
We extended the plasmonic engineering principles to fluorescence enhancement of NIR dyes that 
typically suffer from poor quantum yields.  Specifically, the distance-dependent fluorescence 
enhancement of NIR dyes in proximity to gold nanostructures is explored using layer-by-layer 
assembled polymer multilayer as a dielectric spacer.  We noted nearly three order magnitude 
enhancement in fluorescence signals under optimal conditions. The study lays the groundwork for 
the design and synthesis of extremely bright Raman and fluorescence probes based on optimal 
design of plasmonic nanostructures.  The design principles established here can be extended to 
other Raman reporters and fluorescent dyes to achieve a suite of optical probes for highly sensitive, 
precise and accurate bioimaging.  
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Chapter 1  
Introduction to Plasmonic Nanomedicine 
 
1.1 Localized Surface Plasmon Resonance 
Surface plasmon involves the collective coherent oscillation of the conductive electrons at 
the interface of a metal and dielectric material.   A broad term, plasmonics involves the 
control of light at the nanoscale using surface plasmons, which encompasses such unique 
optical phenomena as highly localized enhancement of electromagnetic (EM) field at 
nanostructured metal surface, high sensitivity of the surface plasmon resonance to external 
medium, extraordinary transmission through sub-wavelength apertures in thin metal films,  
and sub-wavelength waveguiding in metal nanostructures.  Plasmonics is gaining immense 
interest due to potential applications of the aforementioned phenomenon in nano-optical 
components for plasmonic circuits, fabrication of nanoscale structures, photovoltaics, and 
chemical/biological sensors.[1]  
 
The time varying electric field of the electromagnetic radiation causes oscillation of 
conductive electrons in the nanoparticles. The resonance of such oscillation, termed 
localized surface plasmon resonance (LSPR), falls into the visible regime for noble metals 
such as gold, silver and copper.  The LSPR of metal nanostructures is sensitive to numerous 
factors such as composition, size, shape, dielectric ambient, and proximity to other 
nanostructures via plasmon coupling. The sensitivity of LSPR to localized changes in 
Figure 1.1 – UV-Visible extinction (black), absorption (red), and scattering (blue) 
of Ag nanoscrystals, illustrating the effect of shape on spectral characteristics: (a) 
sphere, (b) cube, (c) tetrahedron, and (d) octahedron.[2] 
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dielectric environment renders it an attractive transduction platform for chemical and 
biological sensing. 
 
The localized surface plasmon resonance of metal nanoparticles can be tuned based on size, 
geometry, and composition.  Spherical nanoparticles are isotropic and will have a single 
LSPR peak, but can be tuned with size.  Increase in nanoparticle size will red shift the LSPR 
peak, and conversely the smaller nanoparticles will exhibit a blue shifted peak in comparison. 
Growing subsequent shells around the spherical cores can grow spherical nanoparticles to 
larger sizes. Asymmetric growth continues the red shift trend as the size is increasing 
although not isotropically.  Other geometries have more complex features on a UV-Vis 
spectrum. Nanorods are anisotropic and exhibit two peaks, the longitudinal LSPR and 
transverse LSPR.  The transverse band is not very sensitive to the diameter and length of the 
nanorod; however, the longitudinal band is highly sensitive to the aspect ratio of the 
nanorods.  The longitudinal band exhibits a red shift with an increase in aspect ratio.  Other 
anisotropic nanostructures such as nanostars exhibit a broad peak, which is due to the large 
variation is topography of the structures.  Although, less explored composition of the 
nanostructures also provides additional handles in tuning the LSPR of plasmonic 
nanostructures.  In this study, we demonstrate compositionally asymmetric nanostructures 
using kinetic control in the seed-mediated growth of core-shell nanostructures.  
Figure 1.2 – (a) a surface plasmon polariton and (b) a localized 
surface plasmon for metal nanospheres.[3] 
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1.2 Surface Enhanced Raman Scattering 
Despite the rich molecular information provided by Raman spectroscopy, the technique was 
not considered to be a practical analytical tool (let alone detection tool) due to the extremely 
weak signal intensity of normal Raman scattering, a result of the extremely small scattering 
cross-section for most molecules except some special cases (e.g. resonance Raman 
scattering). Hence, for the longest period after its discovery, Raman scattering remained 
limited to “bulk” material investigations. 
 
Surface enhanced Raman scattering (SERS) involves dramatic enhancement in the intensity 
of the Raman scattering from the analyte adsorbed on or in proximity to a rough (nanoscale) 
metal surface.  Despite the initial controversy, at present there is consensus that the 
enhancement of the Raman signal originates from two distinct contributions, namely, 
electromagnetic enhancement and chemical enhancement with the former effect being 
several orders of magnitude higher than the later.  When the excitation light is in resonance 
with the plasmon frequency of the metal nanoparticle, it radiates a characteristic dipolar 
radiation causing a characteristic spatial distribution in which certain areas show higher 
intensity, which is manifested as an electromagnetic enhancement.  Analyte molecules 
subjected to this enhanced electromagnetic field exhibit a dramatic enhancement in Raman 
scattering.  Electromagnetic enhancement critically depends on numerous factors such as 
distance between the metal nanostructures, size and shape (i.e. antenna effect) of the 
nanostructures, composition of the metal nanostructures, and the excitation wavelength with 
respect to the plasmon resonance of the metal nanostructures.   
 
1.3 Plasmonics in Nanomedicine 
One area, in particular, where plasmonics is expected to make an enormous impact is the 
field of life sciences with applications in high-contrast imaging, and non-invasive or 
minimally invasive diagnostics and therapeutics.  Based on the sensitivity of the surface 
plasmon resonance to the dielectric ambient and the enhancement of EM field in proximity 
to metal nanostructures, two important classes of plasmonic biosensors are being actively 
investigated (see Figure 1.3).   
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Conventional SPR sensors rely on propagating surface plasmons at the interface of thin 
metal films and a dielectric medium.  The sensitivity of the surface plasmon resonance (SPR) 
to the changes in the dielectric ambient is exploited in SPR based sensing, which is currently 
a well-established technique for biosensing and probing thermodynamic and kinetic aspects 
of biomolecular binding.[5,6]   Although extremely sensitive, conventional SPR suffers from 
complexity in exciting the surface plasmons (requiring complex optical alignment or special 
substrates such as prisms) and more importantly lacks the spatial resolution to address single 
or few molecule events.       
 
On the other hand, excitation of surface plasmons in metal nanostructures (significantly 
smaller than the wavelength of light) does not require a specialized setup, simplifying the 
operation and making them more appropriate for on-chip, point of care, and cost-effective 
diagnostics.  The time varying electric field of the electromagnetic radiation causes oscillation 
of conductive electrons in the nanoparticles. The resonance of such oscillation, termed 
localized surface plasmon resonance (LSPR), falls into the visible regime for noble metals 
such as gold, silver and copper.  LSPR of metal nanostructures is sensitive to numerous 
factors such as composition, size, shape, dielectric ambient, and proximity to other 
nanostructures (plasmon coupling).[7,8] The sensitivity of LSPR to localized changes in 
dielectric environment renders it an attractive transduction platform for chemical and 
biological sensing.[9,10,11,12,13] LSPR overcomes the above mentioned deficiencies of the 
Figure 1.3 –There are two important classes of plasmonic biosensors: surface 
plasmon resonance biosensors and surface enhanced Raman scattering 
biosensors. 
 
 
5 
conventional SPR approach due to the simplicity of exciting surface plasmons in metal 
nanostructures and the ability to address the same analytes down to single nanostructures 
enabling high lateral resolution and single molecule detection.[14,15] One fundamental question 
that immediately arises is the sensitivity of LSPR sensors in comparison to the conventional 
SPR approach.  In a recent study, Käll and co-workers have demonstrated that the sensitivity 
of LSPR and SPR are comparable from a biosensing standpoint.[16] Although SPR exhibited 
higher refractive index sensitivity and figure of merit (refractive index sensitivity/full width 
at half maximum of the SPR) compared to LSPR, much smaller decay length of the LSPR 
compared to the SPR imparts higher surface sensitivity to LSPR, thus making it equally 
sensitive in biosensing applications.  In summary, LSPR offers distinct advantages compared 
to traditional SPR approach: (i) low bulk sensitivity (ii) simplicity in detection (iii) high spatial 
resolution down to single nanoparticle and (iv) facile integration with device platforms for 
developing point of care assays.  These favorable traits form the rationale behind our choice 
of LSPR as a transduction platform for the present study.  
 
SERS is being investigated for the fabrication of highly sensitive label free biosensors and as 
an imaging tool from a biomedical standpoint,.  Biosensors based on SERS can be broadly 
classified into labeled and label-free approaches (see Figure 1.3).  In the labeled approach, 
Raman marker (reporter molecules) and captured biomolecules are bound to metal 
nanostructures.  Upon binding of this composite nanostructure to the target analyte, the 
Raman signal from the Raman marker is detected and quantified to estimate the analyte 
concentration.  Apart from its application in in vitro biosensors, the labeled SERS approach 
has also been demonstrated to be valuable in imaging tumors by targeted accumulation of 
gold nanostructures.  An alternate approach (label-free) involves binding of the analyte to 
the metal nanostructure functionalized with the captured biomolecule followed by the 
detection and quantification of the Raman scattering from the analyte itself.  The inherently 
narrow Raman bands as opposed to broad fluorescence bands enable multiplexed detection 
of multiple analytes in a complex mixture.  Both labeled and label-free approaches are being 
extensively investigated for the detection of a wide variety of biological species.   
 
SERS is also being extensively investigated as a bioimaging modality, especially for 
intraoperative settings.  SERS is particularly attractive in molecular bioimaging owing to its 
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(i) large multiplexing ability; (ii) excellent photostability compared to organic dyes; (iii) 
absence of interference from water (iv) high spatial resolution; and (v) use of bioinert 
materials such as gold. However, SERS based bioimaging remains a challenge due primarily 
to the lack of bright, easy-to-synthesize, stable and reproducible SERS probes.  Except for a 
few reports, most of the current SERS probe (i.e., contrast agents) designs typically involve 
individual plasmonic nanostructures uniformly appended with Raman reporters, which offer 
limited SERS enhancement and suffer from poor stability due to desorption or enzymatic 
degradation of the Raman reporters in physiological environment.   Extensive efforts have 
been dedicated to developing novel instrumentation and techniques that facilitate the 
deployment of SERS-based bioimaging in clinical settings and imaging of deep tissues.  
Intraoperative hand-held device is an excellent tool for a surgeon to identify tumor margins 
and satellite nodules during surgical procedures. Nie and co-workers have developed a hand-
held spectroscopic device called SpectroPen that enables wavelength-resolved fluorescence 
and Raman measurements for in vivo and intraoperative SERS-based bioimaging 
applications.[17]   A different line of efforts are focused on enhancing the depth of imaging.  
It is known that commonly employed backscattering geometry suffers from limited depth of 
penetration (few mm) even in NIR range due to highly diffusive nature of living tissue. An 
alternate method known as spatially offset Raman spectroscopy (SORS) involves spatially 
offsetting the collection of Raman scattered light from the excitation regions (i.e., laser 
incident regions), which enables the collection of diffuse component of scattered light as 
opposed to conventional ballistic and snake photons in backscattering geometry, thus 
significantly enhancing the depth of probing.  Recently this method has been integrated with 
SERS resulting in spatially offset SERS (SESORS), which enables significantly deeper 
probing into mammalian tissue.[18]  Multiplexed Raman signals emanating from SERS probes 
buried 25 mm deep inside a porcine tissue were successfully collected and analyzed by 
offsetting the excitation and collection by 180° i.e., transmission Raman spectroscopy, a 
special case of SORS.  More recently, Gambhir and co-workers have integrated a fiber optic-
based Raman spectrometer with a white light endoscope to perform Raman imaging of 
human colon.[19]   In a different line of efforts, Bhatia and coworkers have demonstrated 
implantable NIR sources, which overcome the depth limitation associated with NIR light-
based therapies.[20] 
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Multifunctional nanostructures that enable targeted and externally-triggered delivery of 
therapeutic agents along with non-invasive tracking and monitoring of the therapy process 
are a holy grail in nanomedicine.  Different classes of nanomaterials including 
supramolecular assemblies, polymer capsules, and hollow metal nanostructures are 
extensively investigated for such applications.[21,22,23,24,25,26,27,28,29,30,31,32,33] However, in most of 
these cases, it is difficult to track the drug carrying vehicle and to monitor the therapeutic 
response in a noninvasive- or minimally-invasive manner.  Even in the case of nanocarriers 
that comprise of a fluorescent tag, photobleaching of the dyes severely limits the duration 
over which the carrier can be tracked. Additionally, spontaneous release of drugs based on 
biological or intrinsic factors typically results in inadvertent deposition on normal tissue, 
leading to deleterious side effects. Therefore, the design and fabrication of multifunctional 
nanostructures, which can not only carry and release payload with an external trigger but also 
be amenable to non-invasive tracking of the carriers and the extent of drug release over long 
periods, is critical to enhance the efficacy of locoregional chemotherapy.  In this study we 
have designed and demonstrated a novel class of multifunctional plasmonic nanostructures 
for image-guided therapies.   
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Chapter 2  
Bimetallic Janus Nanostructures via Programmed 
Shell Growth 
 
2.1 Abstract 
We report the synthesis of compositionally asymmetric, core-Janus shell plasmonic 
nanostructures comprised of Au and Ag.  Kinetic control was employed to achieve 
asymmetric shell growth on Au nanoparticles acting as cores.  Subsequent differential surface 
functionalization of the nanostructures enabled programmed shell growth resulting in core-
Janus shell nanostructures.  UV Vis extinction spectra reveal that the localized surface 
plasmon resonance of the nanostructures depends on composition and distribution of the 
components, providing additional handles for tuning the optical properties of metal 
nanostructures.  The core-Janus shell nanostructures demonstrated here are highly Raman-
active making them attractive candidates for Raman-based biosensing and bioimaging 
applications. 
 
2.2 Introduction 
We have produced a bimetallic nanostructure, which is asymmetric.  These are called gold 
and silver  Janus nanostructures.  The term ‘Janus’ structure comes from the Greek god of 
doorways, Janus. This Greek god had two opposite facing faces, which represent looking to 
the future as well as the past.  The nanoparticles are half silver and half gold, each with its 
own hemisphere.  The mechanism for this type of growth is highly dependent on the 
kinetics of the reaction. 
 
Localized surface plasmon resonance (LSPR), which involves the collective oscillation of 
dielectrically confined conduction electrons in metal or heavily-doped semiconducting 
nanostructures, enables the confinement of light to regions with sub-wavelength dimensions. 
Optical properties of metal nanostructures strongly depend on the size, shape, composition, 
dielectric environment, and inter-particle coupling of metal nanoparticles.[34-38] Shape and 
composition of metal nanostructures are two important handles that provide large tunability 
in the optical properties of metal nanostructures.[39, 40] Last decade has witnessed tremendous 
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progress in the synthesis of size- and shape-controlled metal nanostructures using, for 
example, seed-mediated and polyol methods.[34, 36]  This progress in chemical synthesis of 
optically-tunable metal nanostructures has reflected in remarkable advancement in the 
fundamental understanding of their complex optical properties and numerous applications 
from biomedicine to photovoltaics.[41-43]   
 
There has been a growing interest in composition-controlled bimetallic nanostructures 
owing to the synergistic properties of the constituent materials.[44] The optical properties of 
such bimetallic nanostructures depend not only on the composition but also to the relative 
distribution of the components within the nanostructures.[45] For example, gold and silver 
exhibit distinct and strong plasmon bands and together they cover the entire range of visible 
and parts of near infrared spectrum. Uniform Au-Ag alloy, core-shell, and asymmetric 
nanostructures have been synthesized using different reaction conditions.[39, 45, 46] Recently, it 
has been demonstrated that by controlling the kinetics of seed-mediated growth, site-
selective growth of Ag and Au on Pd seeds can be achieved.[47] In particular, rate of addition 
of the precursor, capping agent, reductant, and reaction temperature play a critical role in 
controlling the growth of Ag and Au on Pd seeds. However, bimetallic Janus shell 
nanostructures comprised of Au and Ag have never been reported in the past. These kinds 
of precisely engineered bimetallic nanoparticles have several advantages in sensing, catalysis 
and photovoltaic applications due to their synergistic optical and catalytic 
properties.[42,45,46,48,49]  
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Here, to the best of our knowledge, for the first time we report the synthesis of Au/Ag 
bimetallic Janus shell nanostructures. Bimetallic Janus shell nanostructures are realized in 
three steps: (i) synthesis and surface modification of 20 nm spherical gold nanoparticles, 
which serve as seed for bimetallic nanostructures; (ii) kinetically-controlled formation of Au 
semishell on the template nanoparticles; and (iii) differential surface modification of core-
semishell structures for programmed silver growth to form Janus shell (Au-Ag) 
nanostructures (Figure 2.1 A, 2.2 A).  We also demonstrate the intense SERS activity of such 
Figure 2.1 - Kinetically-controlled formation of Au core-semishell nanostructures. (A) A 
Schematic illustrating the mechanism of kinetically-controlled formation of core-
semishell nanostructures. TEM images of (B) 20 nm Au nanoparticles, which were used 
as cores to synthesize core-semishell nanostructures after ligand exchange with BDT. 
(C-D) core-shell structures at intermediate stages of shell growth for both fast (C) and 
slow (D) reaction rates. (E) core-semishell and (F) core-shell Au nanostructures 
obtained by fast and slow growth rate of Au shell on Au cores, respectively. High-
resolution TEM images of (G) core-semishell and (I) core-shell Au nanostructures 
described above. (H) Extinction spectra of Au cores, BDT-modified cores, core-shell 
(BRIGHTs), and core-semishell nanostructures. (Note: reaction conditions for fast and 
slow kinetics are included in materials and methods in supporting information) 
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nanostructures, which makes them ideal candidates as probes in SERS based bioimaging, 
biosensing and anti-counterfeit applications. 
 
2.3 Synthesis of Bimetallic Nanostructures 
The first step towards the synthesis of plasmonic nanostructures with asymmetric 
composition involves the synthesis of nanostructures with asymmetric core-shell structure.   
Figure 2.1 A illustrates the synthetic approach for the formation of Au core-semishell 
nanostructures.  We employ kinetic-control for the growth of the semishell on the cores.  
Specifically, Au nanoparticles of 20 nm diameter capped with cetyltrimenthylammonium 
chloride (CTAC) were employed as cores (Figure 2.1B). The ligand on the Au nanoparticles 
was exchanged with 1,4-benzenedithiol, which is known to bind to Au through cleavage of -
SH bond.   The ligand exchange resulted in a nearly 3 nm red-shift in the LSPR wavelength 
of the Au cores (Figure 2.1H), which indicates the formation of a dense 1,4-Benzenedithiol 
(BDT) layer on the cores.   A shell of desired thickness and morphology is grown by adding 
gold precursor (HAuCl4), reductant (ascorbic acid), and surfactant (CTAC) to stabilize the 
core-shell structures. The morphology of the Au shell on cores can be kinetically controlled 
during shell nucleation and growth processes.  The kinetics of the shell growth reaction was 
adjusted by varying the concentration of ascorbic acid in growth solution.  Higher amount of 
ascorbic acid in the growth solution resulted in faster shell growth rate and in turn resulted 
in the formation of two to four discrete nucleation sites on BDT-modified cores (Figure 
2.1C).  These nuclei tend to grow and form a semishell (50-70%) on the surface of the core 
(Figure 2.1E).  On the other hand, slow growth rate resulted in a rough but uniform shell 
possibly through multiple nucleation events on the surface of the BDT-modified cores 
(Figure 2.1D).  Growth of such nuclei resulted in a uniform dodecahedral core-shell 
nanostructures (Figure 2.1F).  We have previously demonstrated the high Raman intensity of 
such uniform core-shell nanostructures (as we called them BRIGHTs) and their application 
in SERS-based bioimaging.[41]   The UV/vis extinction spectra of the nanostructures 
demonstrate a significant red-shift in the LSPR wavelength of the core-shell nanostructures 
in agreement with our previous report.[41] Interestingly, the core-semishell structures exhibit a 
broad shoulder at higher wavelengths (λ=600-730 nm), which corresponds to the coupling 
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between the core and asymmetric semishell in agreement with previous reports involving 
such core-semishell structures.[50] 
 
The core-semishell nanostructures are then employed as templates to synthesize bimetallic 
Janus nanostructures. Bimetallic Janus nanostructures are synthesized by selectively growing 
silver on the exposed regions of the core of core-semishell nanostructures (Figure 2.2A). To 
achieve the preferential growth of silver on the exposed regions of the core, the shell surface 
of the core-semishell structures was passivated with thiol-terminated poly(ethylene glycol) 
(SH-PEG).  Addition of SH-PEG to core-semishell nanostructures resulted in the exchange 
of CTAC ligand on the semishell surface with SH-PEG, while the exposed regions of BDT-
modified core remain intact.  Subsequent addition of silver precursor (AgNO3) resulted in 
the formation of a silver shell in the exposed regions, resulting in bimetallic core-Janus shell 
nanostructures (Figure 2.2 D).  Higher resolution TEM image clearly demonstrates the Janus 
nanostructures with asymmetric composition (Figure 2.2G).   Addition of silver precursor to 
Figure 2.2 - Programmed shell growth using differential surface functionalization for 
realizing Janus bimetallic nanostructures.  (A) Schematic representation of differential 
surface functionalization for programmed shell growth. TEM images of Au core-
semishell nanostructures (C), Bimetallic Au/Ag core/shell nanostructures (B,E), and 
Bimetallic core-Janus shell nanostructures (D,G). (F) Extinction spectra of various 
nanostructures described above. 
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core-semishell structures without surface passivation step resulted in uniform silver shell on 
the entire core-semishell structure (Figure 2.2B, E).  Clearly, differential surface 
functionalization is important to induce the growth of silver at desired locations on core-
semishell structures and yield bimetallic core-Janus shell nanostructures.  As mentioned 
above, the optical properties of bimetallic metal nanostructures depend on composition and 
distribution of the components.  Extinction spectra of core-Janus shell nanostructures 
exhibited two bands corresponding to LSPR of Au (530 nm) and Ag (420 nm) with the 
LSPR band corresponding to Au significantly stronger than Ag owing to the small amount 
Ag (semishell) compared to Au (core+semishell).  On other hand, core-semishell structures 
with uniform growth of Ag over the entire structure exhibited stronger LSPR band 
corresponding to Ag.  
 
2.4 SERS Performance 
Such core-shell and core-Janus shell plasmonic nanostructures with Raman-active molecules 
trapped between core and shell are extremely attractive as bright SERS tags.[46, 50]  In fact, we 
have recently demonstrated that the Raman scattering from reporters (BDT) trapped 
between core and shell of a gold nanostructure is dramatically enhanced.[41]  The SERS 
enhancement factor of such core-shell nanostructures is ~2×1011, making them ultra-bright 
nanostructures for bioimaging applications. SERS spectra obtained from various 
nanostructures using two excitation sources (514 and 785 nm) is shown in Figure 2.3.  As 
expected, we did not observe any detectable Raman signal corresponding to BDT from 
Figure 2.3 - Surface enhanced Raman scattering spectra of cores, core-semishells, 
bimetallic Au/Ag core/shells, and bimetallic core-Janus shell nanostructures obtained at 
both 785 and 514 nm of laser excitation sources. The band indicated with asterisk (*) in 
the spectrum from cores corresponds to the Raman band from the silicon substrate. 
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BDT-modified cores.  Core-semishell nanostructures exhibited small but finite (955 cps) 
Raman signal with 785 nm excitation but no discernible Raman signal was observed using 
514 nm excitation. This is possibly due to the plasmon resonance mismatch with excitation 
wavelength. Unlike core-semishell, core-shell structures showed reasonable signal intensity 
(1203 cps) under 514 nm excitation due to strongly match between plasmon resonance and 
excitation wavelength. On the other hand, core-Janus shell nanostructures exhibited the 
highest Raman intensity (3525 cps) among all these nanostructures with 785 nm excitation. 
Such strong Raman signal corresponds to plasmon coupling between the core and Janus 
shell, which results in enhanced EM field within the tiny gap between the core and shell, 
thus resulting in large SERS enhancement.[51]  
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Chapter 3 
Multifunctional Nanorattles for Spectrum Guided 
Locoregional Therapy 
 
3.1 Abstract 
We demonstrate that a combination of photothermal ablation of the plasmonic nanorattles 
and triggered release of chemotherapeutic drug from the nanorattles can induce locoregional 
death of cancer cells in vitro. The completion of therapy process is indicated by a “Raman 
signal flip” between the two reporters of the SERS probe. Simple yet powerful approach to 
non-invasively monitor the therapy process serves as a new tool for precise control over the 
therapy process using plasmonic nanostructures. 
 
3.2 Introduction 
Nanotechnology holds great promise to achieve revolutionary advances in virtually all 
aspects of medicine including in vitro diagnostics, bioimaging, targeted, and externally-
triggered therapy, image-guided surgery, and regenerative medicine. Multifunctional 
nanostructures that enable targeted and externally-triggered delivery of therapeutic agents 
along with non-invasive tracking and monitoring of the therapy process are a holy grail in 
nanomedicine.[52] Different classes of nanomaterials including supramolecular assemblies, 
polymer capsules, and hollow metal nanostructures are being extensively investigated for 
such applications.[53] However, in most of these cases, it is difficult to track the drug carrying 
nanovehicles over a long period to monitor the therapy process and therapeutic response 
non-invasively. Therefore, the design and fabrication of multifunctional nanostructures, 
which not only carry and release payload with an external trigger but are also amenable to 
non-invasive tracking of their location, extent of drug release, and progress of the therapy 
over long periods, is critical to enhance the efficacy of locoregional cancer therapy. In the 
last few years there have been significant efforts to employ hollow plasmonic nanostructures 
as drug carriers.[52b, 54] In particular, Xia and co-workers have demonstrated that 
chemotherapeutic drug can be encapsulated and released from gold nanocages using external 
trigger such as near infrared (NIR) laser or high-intensity focused ultrasound.[54b] A 
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temperature responsive polymer or phase change material is employed as a ‘gate keeper’ to 
contain or release the drug.[55] 
 
We design and demonstrate multifunctional plasmonic nanorattles as nanocarriers to deliver 
therapeutics and to non-invasively monitor the therapy process. Plasmonic nanorattles are 
comprised of a surface enhanced Raman scattering (SERS) probe trapped in a porous gold 
shell. The SERS probe employed here is an upgraded version of the recently introduced 
SERS probe known as bilayered Raman-intense gold nanostructures with hidden tags 
(BRIGHTs).[56] Unlike BRIGHTs, which are comprised of one Raman reporter (1,4-
benzenethiol (BDT)) trapped between Au core and shell, nanorattles are comprised of two 
Raman reporters. The two reporters (BDT and naphthalenethiol (NT)) molecules are 
precisely placed at distinct locations in the nanorattle. The SERS response of the nanorattles 
is governed by the morphological state of these nanostructures, which is used to monitor the 
therapy process. Irradiation with a NIR laser causes fragmentation of the outer shell of 
nanorattles and release of the drug encapsulated within. The fragmentation of the 
nanorattles is also associated with a dramatic switch in the SERS signal between the two 
reporters (BDT and NT) indicating the drug release. To the best of our knowledge, this is 
the first report describing multifunctional nanostructures which enable targeted delivery of 
payload with simultaneous monitoring of the payload release and the therapy process using 
SERS. 
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3.3 Synthesis of Multifunctional Nanorattles 
Various steps involved in the synthesis of multifunctional nanorattles are illustrated in Figure 
3.1A. Synthesis of the multifunctional Au nanorattles starts with the synthesis of BRIGHTs 
as described previously,[56a] followed by chemisorption of second Raman reporter (NT) on 
the surface of these nanostructures. Briefly, BRIGHTs are comprised of BDT (employed as 
Raman reporters) trapped between Au core (20 nm diameter) and Au shell (25 nm thickness) 
(Figure 3.1B). Subsequently, a thin shell of Ag (~20 nm) is grown on the surface of NT-
modified BRIGHTs (Figure 3.1C). Galvanic replacement reaction is employed to convert 
Figure 3.1 - Synthesis and drug loading into multifunctional nanorattles. A) Schematic representation of the 
synthesis of plasmonic nanorattles using BRIGHTs as cores. B) Transmission electron microscopy (TEM) 
image of BRIGHTs. Lower inset: TEM image of the core Au nanoparticles. C) TEM image of 
Ag@BRIGHT nanostructures, which shows ∼ 20 nm thick silver shell on BRIGHTs. D) TEM image of 
nanorattles revealing BRIGHT trapped in a porous Au shell. E) TEM image of drug-loaded nanorattles, 
which preserved their rattle structure during the drug loading process. Insets in (B–E): Corresponding 
schematic representation in (A). F) UV-vis extinction spectra of all the nanostructures mentioned above, 
depicting the evolution of the optical properties of Au nanorattles. Photographs of solutions of BRIGHTs, 
Ag@BRIGHTs, and nanorattles in Falcon centrifuge tubes. 
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the Ag shell into a porous gold shell with BRIGHTs trapped inside (Figure 3.1D).[57] It is 
known that galvanic replacement of Ag nanostructures results in the formation of porous 
and hollow gold nanostructures, which have been employed as drug delivery agents.[54a,54c] 
The space between BRIGHT and outer shell is filled with a mixture of biocompatible phase 
change material (1-tetradecanol) and a chemotherapeutic drug (doxorubicin (Dox)) (Figure 
3.1E). 1-Tetradecanol, which is known to exhibit a phase change from solid to liquid at 
around 39°C[55], serves as a gate keeper to contain or release drug from porous plasmonic 
nanostructures with external trigger such as light or ultrasound. [52b, 54b] 
 
UV-vis extinction spectra reflect the changes in structure and composition of the 
nanostructures at various stages of synthesis (Figure 3.1F). BRIGHTs exhibit a LSPR band 
centered at 535 nm that is red-shifted and slightly broader compared to that of the Au 
nanoparticles employed as cores. Formation of a thin Ag shell on the BRIGHTs results in a 
new band at lower wavelength (410 nm) associated with Ag and ~46 nm blue shift in the 
LSPR wavelength of BRIGHTs. Following the galvanic replacement reaction, LSPR 
corresponding to Ag at lower wavelength completely disappeared with a concomitant 
emergence of a higher wavelength LSPR band (800 nm), which appears as a shoulder to 
slightly red-shifted BRIGHT’s LSPR band at 550 nm. The red-shift in the BRIGHTs band is 
possibly due to the plasmonic coupling between the BRIGHT and the porous gold shell. 
The higher wavelength band, similar to that observed in Au nanocages obtained by using Ag 
nanocubes as templates, can be easily tuned by controlling the amount of gold salt added in 
the galvanic replacement reaction (Figure S3 Appendix C). In the present study, we 
employed 785 nm laser as the excitation source for obtaining SERS spectrum and 808 nm 
laser for photothermally heating the nanorattles. Thus, plasmonic nanorattles with LSPR 
wavelength at ~800 nm are ideal for both of these purposes.  
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3.4 SERS Performance 
Now we turn our attention to SERS properties of the nanorattles. The nanorattles are 
comprised of two Raman reporters, namely, BDT and NT, located at two distinct locations 
as shown in Figure 3.2. BRIGHTs exhibit strong Raman scattering corresponding to 
BDT[56a] with 785nm excitation (Figure 3.2), which is trapped in between the core and shell 
of the BRIGHT structure. On the other hand, SERS signal from nanorattle corresponds to 
NT Raman bands (1378 cm-1 band corresponding to the ring stretch mode clearly 
distinguishes NT from BDT as shown in Figure 3.2[58], which is adsorbed on the surface of 
BRIGHTs. This is possibly due to the electromagnetic (EM) coupling between the porous 
Au shell and BRIGHT, which causes the NT molecules to reside at EM hot spots, thus 
dramatically enhancing their Raman scattering. These binary SERS-active nanostructures can 
be employed for probing the therapy process as will be demonstrated below. Briefly, laser 
ablation of nanorattles leads to rupture of the porous shell (TEM images in Figure S12 
Appendix C), which in turn results in a “Raman signal flip” from NT to BDT. Complete flip 
in the SERS signal from NT to BDT indicates the rupture of the nanorattles and the 
completion of combination therapy by hyperthermia and release of chemotherapeutic drug.  
 
3.5 Nanorattle Drug Delivery System 
We demonstrate externally-triggered therapeutic efficiency of the nanorattles in vitro using 
epithelial breast cancer cells (SKBR3). Methylthiazolyldiphenyl-tetrazolium bromide (MTT) 
assay was employed to probe the viability of SKBR3 cells incubated with various 
concentrations of nanorattles. Up to a concentration of 5 nM of nanorattles or nanorattles 
loaded with tetradecanol, the cell viability was found to be higher than 90% (Figure 3.3). The 
Figure 3.2 - Schematic depicting the location of BDT and 1-
naphthalenethiol in the multifunctional nanorattle. SERS spectra 
corresponding to BRIGHTs and nanorattles are also depicted, which are 
dominated by BDT and NT signals, respectively. 
 
 
 
20 
viability of cells incubated with 5 nM of tetradecanol-loaded nanorattles was found to be 
higher than 90% even with 808 nm laser irradiation (63.5 mW/cm2 for 30 sec) indicating that 
the photothermal heating of the nanorattles at this laser power is insufficient to induce 
significant cell death (Figure 3.3). However, upon an increase of the laser power to 
254mW/cm2, the cell viability dropped to below 25%, due to the photothermal heating of 
the nanorattles (Figure S11 Appendix C). These results provide guidelines for the rational 
choice of laser power density to either cause or avoid photothermal destruction of cancer 
cells. Fluorescence microscopy was employed to probe the triggered release of Dox from the 
nanorattles in vitro. Dox is known to exhibit a moderately strong fluorescence emission at 
around 600 nm, which could be employed to monitor the release and distribution of the 
same drug [59]. SKBR3 cells were incubated with Dox-loaded nanorattles in serum-free 
Figure 3.3 - Viability of epithelial breast cancer cells (SKBR3) in the 
presence of nanorattles, nanorattles loaded with tetradecanol, and 
nanorattles loaded with tetradecanol with laser exposure as 
determined by MTT assay. 
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medium for 2 hr at 37°C allowing passive internalization of the nanorattles.[60] Subsequently, 
the serum-free medium was replaced with complete medium and the cells were exposed to 
808 nm laser for 30 sec at 63.5 mW/cm2 power density. Fluorescence images of laser-treated 
cells were collected at 0, 30, 60, 120 min after laser irradiation was observed at 30 min 
(Figure 3.4). Although laser irradiation causes the release of Dox from nanorattles, the 
absence of fluorescence is due to the close proximity of Dox to gold nanostructures, which 
quenches the fluorescence in a non-radiative manner. However, at 60 min, a weak 
fluorescence signal was observed, which indicates the release and diffusion of Dox away 
from the nanorattles. Finally, at 120 min, strong red fluorescence was observed, which 
indicates the successful externally triggered-release of Dox from nanorattles. On the other 
hand, without laser irradiation, no noticeable release of Dox was observed indicating the 
Figure 3.4 - Dox release studies upon laser exposure. Passively 
targeted SKBR3 cells are subjected to laser irradiation to follow the 
Dox release over a period of 120 min. The microscopy images in 
columns 1, 2, and 3 are bright field, dark field, and fluorescence images 
of SKBR3 cells, respectively. The microscopy images in rows A, B, C, 
D are images collected at 0, 30, 60, 120 min, respectively, after laser 
exposure. The fluorescence images in (A3–D3) clearly depict the Dox 
release (red fluorescence) 120 min after laser exposure. 
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absence of leakage or untriggered release of Dox (Figure S13 Appendix C).  
 
Next, we investigate the therapeutic properties of nanorattles and Dox-loaded nanorattles 
with and without laser irradiation using commercially available live/dead viability kit (green 
color for live and red for dead) as shown in Figure 3.5. The cells in row B&C and rows 
D&E are incubated with nanorattles and Dox-nanorattles, respectively, for 2 hrs. Images in 
rows A, C, and E correspond to cells that were irradiated with 808 nm laser at a power 
density of 63.5 mW/cm2 for 30 sec. The fluorescence images were collected after exposing 
the cells to live/dead staining solution for 30 min. The control cells after laser exposure 
exhibit bright green fluorescence, which corresponds to live cells and indicates that the laser 
power density employed here does not cause any cell death (Figure 3.5A3). Dark-field 
images of the cells incubated with nanorattles exhibit perceivable light scattering from the 
plasmonic nanostructures, confirming the passive uptake of the nanorattles by SKBR3 cells 
(Figure 3.5B2-E2). Uptake of the unfilled nanorattles itself does not cause any significant cell 
death as deduced from the strong green fluorescence from the cells and absence of any red 
fluorescence (Figure 3.5B3, 4). Similarly, laser irradiation of cells incubated with unfilled 
nanorattles did not cause any significant cell death (Figure 3.5C3, 4). On the other hand, 
uptake of Dox-loaded nanorattles results in observable change in cell morphology both with 
and without laser irradiation. In the case of unexposed cells (Figure 3.5D1-4), no strong 
staining of either green or red was observed, which indicates unhealthy state of cells. Laser 
irradiation of the cells with internalized Dox-loaded nanorattles resulted in severe cell death 
as indicated by the strong red fluorescence (Figure 3.5E4). These results clearly demonstrate 
that cell death is much faster and effective when incubated with drug-loaded nanorattles and 
irradiated with laser compared to all other cases.  
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MTT assay was employed to quantify the viability of SKBR3 cells incubated with Dox-
loaded nanorattles with and without laser irradiation to further evaluate the effectiveness of 
therapy using plasmonic nanorattles. The viability of the cells was monitored at 4, 12 and 24 
hours after 808 nm laser irradiation of the cells at a power density of 63.5 mW/cm2 for 30 
sec. Our studies show that laser irradiation of cells incubated with drug-loaded nanorattles 
results in significant cell death (with cell viability below 30%) at every measured time point 
shown by brick patterned bars in Figure 3.6. On the other hand, untreated cells (i.e., without 
laser irradiation) for the same time periods show significantly higher viability. For example, 
after 4 hrs, we observed a cell viability of ~90% for untreated cells whereas as the same 
drops to ~25% for laser-irradiated cells. These results demonstrate the rapid response of 
cells to laser irradiation suggesting that the combination therapy works much faster 
compared to individual therapies. These results are also consistent with the drug release 
Figure 3.5 - Live/dead cell monitoring of SKBR3 cells. Columns 1, 2, 3, and 4 are 
bright field, dark field, green fluorescence (live), and red fluorescence (dead) 
microscopy images, respectively. Rows A, B, C, D, and E are only laser, only 
nanorattles, nanorattles + laser, nanorattles + Dox, and nanorattles + Dox + laser, 
respectively. All images collected after 60 min of incubation with ethidium 
bromide live/dead staining reagent. Cells treated with laser, nanorattles, and 
nanorattles + laser show a bright green fluorescence (A3–C3), which is an 
indication that the cells are alive. Cells treated with Dox-loaded nanorattles 
exhibit neither red nor green fluorescence, which is an indication of an unhealthy 
state of cells, possibly due to trace amounts of Dox released from the nanorattles. 
However, for the cells treated with laser light in the presence of Dox-loaded 
nanorattles, most of the cells are found to be dead (strong red fluorescence) as a 
result of the combination of chemotherapy and photothermal therapy. 
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studies discussed above (Figure 3. and Figure S9 Appendix C). Significant cell death over a 
period of 24 hrs even in the case of untreated cells is possibly due to the trace amount of 
Dox that is released from the nanorattles over this long period of time.  
 
3.6 Tracking of Therapy Progress 
As mentioned earlier, nanorattles enable one to follow the therapy process owing to the two 
Raman reporters incorporated into these plasmonic nanostructures. In particular, SERS 
signals from the nanorattles switch from NT to BDT depending on the structural state of 
Figure 3.6 - Viability of SKBR3 cells at different time points (24, 12, and 4 h) with 
and without laser exposure in the presence of nanorattles loaded with 1-
tetradecanol and Dox. 
Figure 3.7 - Spectrum-guided locoregional therapy. Laser ablation of nanorattles 
leads to SKBR3 cell death in regions exposed to laser light, as indicated by red 
fluorescence. Also, the laser ablation leads to SERS signal-flip, which enables one 
to distinguish between live and dead cells as indicated by the Raman spectra 
collected from the two different regions (indicated as 1 and 2). 
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the nanorattles. The intact nanorattles exhibit SERS bands corresponding to NT reporters 
that are on the outer surface of BRIGHTs, whereas rupture of nanorattles results in 
appearance of SERS bands corresponding to BDT. To confirm the switch in the Raman 
signal, we photothermally ruptured the nanorattles using a NIR light (808 nm) as external 
trigger. As expected, when the nanorattles are intact, they exhibit SERS peaks corresponding 
to NT, which upon rupture of nanorattles disappears with concomitant appearance of BDT 
signal.  
 
We employed 808 nm laser with a power density of 254 mW/cm2 to cause rupture of the 
porous nanoshells to demonstrate the possibility of non-invasive monitoring of the 
externally-triggered drug delivery in vitro. It is important note that the combination therapy 
is conducted at high power density compared to drug release studies to induce the 
photothermal therapy and chemotherapy at the same time by laser ablation of nanorattles. 
The laser power required to raise the temperature of the nanorattles to about 400C and 
trigger a slow release of the drug from nanorattles is significantly lower compared to that 
required to achieve complete rupture of the nanorattles. We subjected half of the coverslips 
with 80% confluence of SKBR3 cells to laser irradiation and then collected Raman signals 
from both exposed and unexposed areas of the cells as indicated in Figure 3.7. We observed 
an intense NT SERS signal from the regions unexposed to laser whereas only BDT signal 
was observed from the exposed regions, which indicates that the nanorattles rupture and 
drug is released with laser irradiation (TEM images in Figure S12 Appendix C). We stained 
the cells with ethidium bromide solution and the fluorescence images are depicted in Figure 
3.7 (live/dead), to confirm the locoregional therapy and cell killing. Fluorescence from the 
cells reveal that the regions of the sample exhibiting NT SERS signal correspond to live cells 
(green) whereas the regions exhibiting BDT signal correspond to regions of dead cells (red). 
Considering that SERS can be remotely excited and collected using NIR wavelengths, the 
approach suggested here can be a powerful tool, providing additional tools for controlled 
drug administration.  
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Chapter 4 
Probing Distance-Dependent Plasmon-Enhanced 
Near-infrared Fluorescence Using Polyelectrolyte 
Multilayers as Dielectric Spacer 
 
4.1 Abstract 
Owing to their applications in biodetection and molecular bioimaging, near-infrared (NIR) 
fluorescent dyes are being extensively investigated. Most of the existing NIR dyes exhibit 
poor quantum yield, which hinders their translation to preclinical and clinical settings. 
Plasmonic nanostructures are known to act as tiny antennae for efficiently focusing the 
electromagnetic field into nanoscale volumes. The fluorescence emission from NIR dyes can 
be enhanced by more than a thousand times by precisely placing them in proximity to gold 
nanorods. We have employed polyelectrolyte multilayers fabricated using layer-by-layer 
assembly as dielectric spacers for precisely tuning the distance between gold nanorods and 
NIR dyes. The aspect ratio of the gold nanorods was tuned to match the longitudinal 
localized surface plasmon resonance wavelength with the absorption maximum of the NIR 
dye to maximize the plasmonically enhanced fluorescence. The design criteria derived from 
this study lays the groundwork for ultra-bright fluorescence bullets for in vitro and in vivo 
molecular bioimaging. 
 
4.2 Introduction 
Fluorescence is a highly promising and rapidly emerging molecular imaging modality because 
of the high sensitivity, amenability to targeting, use of non-ionizing radiation and non-toxic 
nature of the contrast agents.[62]  Considering the nearly two order magnitude smaller 
endogenous absorption coefficient and minimal autofluorescence of tissue in the far red and 
near infrared (NIR) part of the electromagnetic spectrum (650-900 nm), NIR dyes are being 
extensively investigated for in vivo characterization of biological processes at the cellular and 
molecular levels.   Over the past decade, there has been tremendous progress in the design 
and synthesis of novel NIR dyes that exhibit absorption and emission in the NIR 
window.[62a, 62c] However, the low quantum yield of most of these dyes limits their adoption 
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into routine in vivo and clinical applications.   Enhancing the brightness of NIR dyes will 
significantly improve the tissue imaging depth achieved with these molecular probes owing 
to the improved signal-to-noise ratio. In addition, the lower the excitation power required 
for fluorescence imaging in vivo minimizes photobleaching and photothermal damage. 
 
Recent reports demonstrate that the quantum efficiency of NIR dyes can be substantially 
improved by “lightning rod effect” of plasmonic nanostructures, often termed as plasmon 
enhanced fluorescence (PEF).[63]  The mechanism of PEF is relatively complex and it 
depends on intrinsic properties of plasmonic nanostructures (e.g., extinction, surface 
roughness) and chromophore (e.g., transition states and quantum yield), as illustrated by 
recent theoretical and experimental studies.[64] Although various reports experimentally 
demonstrate PEF, the design principles for achieving maximum fluorescence remain elusive. 
[64e, 64j, 64k, 65]  Systematically addressing various factors that influence the magnitude of PEF is 
critical for the design of ultra-bright NIR imaging probes. 
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4.3 Nanorods with Polyelectrolyte Dielectric Spacers 
Here, we investigate the distance-dependent fluorescence enhancement using polyelectrolyte 
multilayers as dielectric spacers between NIR chromophores and plasmonic nanostructures 
(Figure 4.1A).  Polyelectrolyte multilayers of poly(allylamine hydrochloride) (PAH) and 
poly(styrene sulfonate) (PSS) were deposited using immersion-based layer-by-layer (LbL) 
assembly method as reported previously.[66]  We employ a low quantum yield (0.1) NIR dye, 
LS288[67], as a model NIR chromophore and gold nanorods as plasmonic nanoantennae to 
probe the plasmon enhanced fluorescence (PEF).   Gold nanorods (AuNRs) offer a distinct 
advantage in that the localized surface plasmon resonance (LSPR) of AuNR can be tuned 
over a broad range, including the NIR wavelengths, by changing the aspect ratio of AuNR.[68]   
The aspect ratio of the AuNR is chosen such that the longitudinal LSPR of AuNR adsorbed 
on glass slide overlapped with the absorption maxima of LS288 (Figure 4.1B).  
Representative TEM image shows AuNR with a diameter of 63±7.3 nm and a length of 
14±1.7 nm, making the aspect ratio ~4.5 (Figure 4.1C).  
 
Figure 4.1 - A) Polyelectrolyte multilayers obtained by layer-by-layer assembly to 
precisely place the dye molecule at a desired distance from the gold nanorods. B) 
Vis-NIR absorption and extinction properties of LS288 and gold nanorods, 
respectively. The absorption maximum of the dye overlaps with extinction spectra 
of gold nanorods with aspect ratio 4.5, which is important to obtain maximum 
fluorescence enhancement. C) Representative TEM image of the gold nanorods 
employed in this study. 
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AuNRs were chemisorbed on mercaptopropyltriethoxysilane (MPTES)-coated glass 
substrates.  To avoid plasmon coupling, which results in broadening of the LSPR band, the 
density of AuNR was limited to 29±3/µm2 (see experimental section for details and Figure 
4.3). Layer-by-layer assembly of PAH and PSS on AuNR was performed by alternate 
immersion of the glass substrates into 1% polyelectrolyte (PSS and PAH) solutions in 0.1 M 
NaCl.[66, 69]  Considering that AuNRs are positively charged, we initiate the multilayer 
deposition with negatively charged PSS and terminate with positively charged PAH, which 
facilitates the electrostatic adsorption of negatively charged LS288.  Deposition of 
polyelectrolyte layers results in a progressive red shift and increase in the intensity of 
longitudinal LSPR of AuNR owing to the increase in the effective refractive index of the 
medium around AuNR (Figure 4.2A). Atomic force microscopy (AFM) at the edge of an 
intentional scratch (scratch test) confirmed the thickness of the polyelectrolyte layers (Figure 
4.2B and Figure S21 Appendix C).  AFM height profile shows a thickness of ~20 nm after 
Figure 4.2 - A) Vis-NIR extinction spectra of the AuNR coated with a different 
number of polyelectrolyte bilayers. B) AFM image along the edge of a scratch 
made in a film comprised of ten polyelectrolyte bilayers. (The inset shows the 
cross-section across the scratch.) C) Fluorescence intensity of LS288 deposited at 
different distances from the AuNR surface using polyelectrolyte bilayers as 
spacers. D) Plot correlating the distance from the AuNR surface to the 
fluorescence intensity and the enhanced electromagnetic field. 
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10 bilayers of PSS and PAH, indicating an average thickness of ~1 nm for each layer (Inset 
in Figure 4.2B). 
 
After the deposition of polyelectrolyte multilayers terminated with PAH, we electrostatically 
adsorb LS288 dye from a dilute aqueous solution (1µM) onto the polyelectrolyte surface 
followed by extensive rinsing to remove any weakly bound dye molecules.  The uniformity 
of the dye adsorption on pristine glass slides was confirmed by mapping fluorescence 
intensity with 1 µm step-size using a confocal fluorescence microscope.  All fluorescence 
measurements were performed using 785nm excitation at very low laser power (0.003mW) 
to minimize photobleaching of LS288.  The fluorescence map exhibited remarkable 
uniformity, confirming the uniform adsorption of the fluorophores on PAH surface with no 
signs of patchiness (Figure S31 Appendix C).  Distance-dependent PEF of LS288 was 
probed by adsorbing the fluorophores at different distances from AuNR surface using 2, 4, 
8, 12, 16, 20, and 24 polyelectrolyte layers as spacers (Figure 4.2C).  Maximum fluorescence 
intensity was observed for a 4 layers-spacer followed by a monotonic decrease in 
fluorescence intensity with increase in the number of polyelectrolyte layers (Figure 4.2 
C&D).  Finally, after 20 polyelectrolyte layers the fluorescence intensity equaled the intensity 
of dye molecules on a PAH-coated glass substrate, indicating that the fluorophores placed at 
~20 nm away from the of AuNR surface are not significantly influenced by enhanced EM 
field of AuNR.  It is worth noting that with increase in the number of bilayers the 
fluorescence intensity decays exponentially similar to EM field decay around the AuNR 
(Figure 2D). [66]   These results suggest that spatial proximity of dye molecules and plasmonic 
nanostructures is critical to attain maximum PEF.   However, when the dye molecules are in 
direct contact or extremely close to AuNRs (~2 nm), non-radiative energy transfer between 
the dye and AuNR leads to dramatic quenching of fluorescence.  The optimum distance 
between the dye and AuNRs is found to be ~4 nm to obtain maximum fluorescence 
enhancement (Figure 4.2D).  Therefore, if the dye is too close or too far from the AuNRs, 
PEF is either diminished due to non-radiative energy transfer or weak EM field, respectively. 
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4.4 Plasmon Enhanced Fluorescence Patterning 
We have employed soft lithography to form a microscale pattern of AuNR on silicon surface 
to further demonstrate PEF of NIR dye in proximity to AuNR.  Specifically, we employed 
capillary transfer lithography to form a pattern of 3 µm-wide polystyrene stripes interleaved 
with 7 µm-wide regions of exposed glass surface.  The exposed glass surface was coated with 
MPTES, followed by chemisorption of AuNR (Figure 4.3B).  Subsequently, two 
polyelectrolyte bilayers were uniformly deposited over the entire surface followed by 
electrostatic adsorption of LS288 as described above.  Fluorescence intensity mapping across 
the micropattern clearly shows the enhanced fluorescence from the AuNR regions compared 
to that from the polystyrene regions.  The enhanced fluorescence from dye molecules spaced 
4 nm away from AuNR clearly demonstrates the PEF of the NIR dye (Figure 4.3D). 
 
 
 
 
 
Figure 4.3 - A) Capillary transfer lithography to ensure large separation between a 
AuNR and a dye. B) AFM images of poly(styrene) (PS) stripes on a glass 
substrate obtained by CTL; scale bar 10 μm. AFM images of AuNRs on a glass 
surface between PS stripes before (C1; no layers; scale bar 1 μm) and after (C2; 
four layers; scale bar 1 μm) deposition of two bilayers of PSS and PAH. D) Map of 
the fluorescence intensity from LS288 uniformly adsorbed on AuNRs and PS 
following the deposition of two bilayers of PSS and PAH; scale bar 5 μm. 
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4.5 Coherence of LSPR and Excitation 
After probing the distance-dependent PEF phenomenon, we explored the relation between 
the optical properties of the components (i.e., LSPR wavelength of plasmonic 
nanostructures and absorption and emission of the dye) and magnitude of PEF. We used 
gold nanorods of three different aspect ratios for this study: 1 (AuNR1), 2.3 (AuNR2.3), and 
4.5 (AuNR4.5) (Figure 4.3A-C).  Aspect ratio enables facile tuning of the LSPR of AuNR 
over a broad spectral range.  In the present study, LSPR wavelength of three different AuNR 
is at 540 (AuNR1), 622 (AuNR2.3) and 820 nm (AuNR4.5) (Figure 4.4D).   Similar 
procedures described above were employed to chemisorb gold nanostructures on glass 
slides, deposit polyelectrolyte multilayers and electrostatically adsorb monolayer of LS288.  
We fixed the dielectric spacer distance at 4 nm for all the nanostructures, which was found 
to be optimal for maximum PEF.   We correlate the fluorescence intensities of LS288 with 
the extinction properties of all three nanostructures (Figure 4.4E). As expected, the PEF is 
primarily determined by the LSPR wavelength of the gold nanostructures.  In the case of 
AuNR1 (i.e., gold nanospheres), the LSPR wavelength is far from the excitation and 
emission maxima of LS288, resulting in no significant enhancement of fluorescence.  
Although the extinction maximum does not completely match with absorption maximum of 
Figure 4.4 - TEM images of nanorods with aspect ratios 4.5 (A), 2.3 (B), and 
nanoparticles (C). D) Vis-NIR extinction spectra of AuNR 1.0, AuNR 2.3, AuNR 
4.5, and LS288 (D). E) Correlation of fluorescence intensity (black) of LS288 and 
electric field intensity (blue) for AuNR 4.5, AuNR 2.3, and AuNR 1.0. 
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dye, the nanorods with an aspect ratio of 2.3 generated ~100 times higher fluorescence 
compared to NPs.  This enhanced fluorescence is possibly due to the partial overlap of 
AuNRs extinction with dye absorption band. Maximum fluorescence enhancement was 
observed when the extinction maximum of AuNR completely matched with the absorption 
maximum of the dye in AuNR4.5.  It is worth noting that the extinction maximum of AuNR 
matched with the dye emission after depositing four polyelectrolyte layers on which the dye 
is adsorbed.   We employed finite-difference time-domain (FDTD) simulations to estimate 
the EM field enhancement at the surface of these nanostructures for 785 nm excitation used 
in this study.  FDTD simulations reveal that the electric field intensity at the surface of 
AuNR4.5 is nearly 8 times higher than that of AuNR2.3, which is in turn 9 times higher than 
that of AuNR1.  Importantly, the PEF followed the same trend as the electric field intensity 
at the surface of these nanostructures under 785 nm excitation (Figure 4.4D-F). 
 
While the above discussed results demonstrate the importance of spectral proximity of 
AuNR LSPR wavelength and absorption maximum of the NIR dye, spatial proximity of the 
dye molecules to AuNR is also a critical factor.  To demonstrate the importance of spatial 
proximity, we chose AuNR with longitudinal LSPR wavelength at 670 nm, which is about 
110 nm lower than the absorption maximum of the dye.  After the chemisorption of AuNR 
on glass substrate, dye molecules were adsorbed on AuNR with 10 polyelectrolyte layers 
spacer.  As described above, deposition of polyelectrolyte layers resulted in a red shift of the 
LSPR wavelength of AuNR to match the absorption maximum of the dye molecules.  
Although the absorption maximum of LS288 matches with the LSPR wavelength of AuNR, 
the fluorescence enhancement was nearly 10 times smaller than that observed for AuNR4.5 
with 4 nm spacer.   
 
Our experiments clearly reveal that the magnitude of PEF depends on the excitation 
wavelength, extinction and emission of dye, extinction of AuNR and distance between 
AuNR and dye.  We can deduce the following design criteria for maximum PEF: (i) the 
absorption maximum of dye and extinction maxima of the metal nanostructures should have 
maximum overlap; (ii) the emission maximum of the dye should also partially overlap with 
extinction band of AuNRs; and (iii) the optimal distance (~4 nm in our study using LS288) 
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between dye molecules and plasmonic nanostructures is obtained by avoiding non-radiative 
energy transfer and ensuring strong electromagnetic field.  
 
4.6 Plasmon Enhance Fluorescence In Solution 
The design principles derived from the substrate-bound AuNR are now applied to AuNR 
dispersed in aqueous solution to achieve ultra-bright NIR fluorescence bullets for 
bioimaging applications.  AuNR were coated with polyelectrolyte bilayers followed by 
adsorption of NIR dye at ~4nm from the surface.  We confirm the charge of the 
polyelectrolyte layers by measuring the zeta potential of AuNR after PSS and PAH coating.  
The charge reversal from positive charge of pristine AuNR to negative charge upon PSS 
coating and subsequent reversal to positive charge with PAH coating confirm the deposition 
of polyelectrolyte coating on AuNR (Figure 4.5B).   Dynamic light scattering (DLS) 
measurements reveal a 4 nm increase in hydrodynamic size after polyelectrolyte coatings, 
which is optimal distance between AuNR and dye for maximum fluorescence enhancement 
(Figure 4.5C).   Fluorescence intensity from the NIR-dye adsorbed AuNR was nearly three 
orders of magnitude higher compared to that obtained from similar concentration of free 
dye in solution (Figure 4.5D).        
Figure 4.5 - A) Vis-NIR extinction properties of AuNR, AuNR+PSS, and 
AuNR+PSS+PAH. B) Zeta potential and C) dynamic light scattering of AuNR, 
AuNR+PSS, and AuNR+PSS+PAH further confirm the successful coating of the 
AuNR with polyelectrolytes. D) Comparison of the LS288 fluorescence intensity 
between a free dye (black) and a dye adsorbed on polyelectrolyte-coated AuNRs 
(red). 
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4.7 Bio Imaging of PEF Probes 
We demonstrate the in vitro bioimaging efficacy of the ultra-bright NIR fluorescence bullets 
using epithelial breast cancer cells (SKBR3).  Three different nanostructures were chosen to 
demonstrate the bioimaging; AuNR4.5, which was found to be optimal for LS288 and 
AuNR2.3, and AuNR1 as controls.  In all cases, the dye was adsorbed at 4 nm from the 
surface.    SKBR3 cells were incubated with 2 ng/ml of AuNR followed by scanning 
confocal microscopy with 785 nm excitation.   Consistent with the results discussed above, 
AuNR1 and AuNR2.3 exhibited low fluorescence intensity.  In contrast, AuNR4.5 exhibited 
very bright NIR fluorescence. We have performed flow cytometry measurements of cells 
incubated with dye and dye-adsorbed AuNR of three different aspect ratios to further 
confirm the enhanced bioimaging ability.  The quantification studies using flow cytometry 
shown in Figure 4.7 are consistent with confocal images in Figure 4.6. The fluorescence 
intensity from cells incubated with optimal aspect ratio AuNR (~4.5) is significantly higher 
Figure 4.6 - Confocal fluorescence microscopy images of passively targeted 
SKBR3 cells with LS288-adsorbed AuNR 1, AuNR 2, and AuNR 4 collected using 
785 nm excitation. The columns 1, 2, and 3 are bright field, fluorescence, and 
merged images of SKBR3 cells, respectively. The microscopy images in rows A, 
B, C, and D correspond to the dye alone, AuNR 1, AuNR 2, and AuNR 4.5, 
respectively. 
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compared to dye and other AuNR samples. These results confirm that the design principles 
obtained from the substrate-bound AuNR could be successfully applied to achieve ultra-
bright fluorescence bullets and their application for in vitro bioimaging.  
 
 
 
 
 
 
 
 
 
Figure 4.7 - Flow cytometry of SKBR-3 (15 000) cells incubated with a dye alone, 
AuNR 1.0+dye, and AuNR 2+dye, and AuNR 4+dye. Cells incubated with AuNR 4 
show a significantly higher fluorescence compared to those incubated with AuNR 1.0 
and AuNR 2. 
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Chapter 5 
Conclusions 
 
5.1 Bimetallic Nanostructures  
We demonstrated that complex bimetallic Ag/Au Janus nanostructures can be achieved by a 
combination of kinetic control and differential surface functionalization. The proof-of-
concept demonstrated here can be extended to other shape-controlled templates such as 
cubes and rods leading to more complex nanostructures with asymmetric composition and 
shape.  Such fine control over the composition serves as a facile handle to finely control the 
optical properties of plasmonic nanostructures.  Such compositionally-asymmetric 
nanostructures bearing synergistic properties of the components can find numerous 
applications in catalysis, imaging, sensing and photovoltaics. 
 
5.2 Multifunctional Nanorattles 
We then introduced a new class of multifunctional plasmonic nanostructures for 
locoregional combination therapy and non-invasive monitoring of the therapy process. 
Considering that SERS can be excited and collected in the therapeutic window (650-900 
nm), the “Raman signal flip”-based monitoring of the therapy process provides additional 
handles for nanomedicine administration. This new class of responsive SERS probes 
integrated with therapeutic agents (e.g., drug delivery vehicles, photothermal contrast agents) 
open new possibilities in image-guided therapy, potentially replacing complex imaging 
systems with simple hand-held Raman devices. Furthermore, with the advent of ultrafast 
Raman imaging systems (e.g., StreamLine™ Plus Raman imaging), this new class of probes 
can potentially replace conventional live/dead staining agents such as ethidium homodimer-
1 and calcein AM, which are prone to photobleaching. [61] 
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5.3 Plasmonic Enhanced Fluorescence 
Lastly, distance-dependent enhancement of fluorescence from dye molecules adsorbed on or 
in close proximity to plasmonic nanoantenna is investigated using LbL assembled 
polyelectrolyte multilayers as dielectric spacers.  A remarkable three order magnitude 
enhancement in fluorescence intensity was observed when the near infrared chromophores 
were spaced ~4 nm from the surface of gold nanorods employed as plasmonic 
nanoantennae.    Increasing the dye-nanorod spacing resulted in a decay of plasmon 
enhanced fluorescence (PEF) that closely followed the decay of electric field intensity from 
the surface of the nanostructures. We demonstrate that significant overlap of the absorption 
and emission of the dye with plasmon extinction band of the plasmonic nanostructures is 
critical for large PEF observed here by precisely tuning the LSPR of the nanoantenna with 
respect to the absorption and emission of the dye.  Based on the design criteria, we 
demonstrate ultra-bright NIR fluorescence bullets that enable significantly improved in vitro 
imaging of breast cancer cells.  The design criteria established here can be readily extended 
to other NIR dyes by precise choice of plasmonic nanostructures and spacing.  We expect 
that these findings will expedite the transition of novel NIR dyes to routine in vitro and in 
vivo applications.  
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Appendix A (Experimental Information) 
 
Experimental (Janus Structures) 
Materials 
All materials were used as received without any further purification. 
Cetyltrimethylammonium bromide (CTAB), gold chloride (HAuCl4.4H2O), sodium 
borohydride (NaBH4), ascorbic acid, 1,4-benzenedithiol (BDT), sodium chloride (NaCl), 
silver nitrate (AgNO3) were purchased from Sigma Aldrich (St. Louis, MO, USA). 
Hydrochloric acid (HCl) was obtained from EMD (Gibbstown, NJ). 
Cetyltrimethylammonium chloride (CTAC) was obtained from TCI (Portland, OR, USA).  
The carbon coated copper TEM grids were acquired from Ted Pella Inc. (Redding, CA, 
USA). Nanopure water (>18.0 MΩ-cm) was used for all experiments. 
 
Characterization 
TEM images were obtained using either field emission TEM (JEM-2100F, JEOL) operating 
at an accelerating voltage of 200 kV or FEI sprint Lab6 with an accelerating voltage of 120 
kV.  UV/vis extinction spectra were collected using a Shimadzu 1800 spectrophotometer.   
Raman spectra were collected using a Renishaw inVia confocal Raman spectrometer 
mounted on a Leica microscope with 50× objective (NA = 0.90) in the range of 100 -3200 
cm-1 with one accumulation and 10 sec exposure time.     
 
Experimental (Nanorattles) 
Materials 
All materials were used as received without any further purification. 
Cetyltrimethylammonium bromide (CTAB), gold chloride (HAuCl4.4H2O), sodium 
borohydride (NaBH4), ascorbic acid, sodium chloride (NaCl), 2-naphthalenethiol (NT), 
polyvinylpyrolidone (PVP (29000 MW)), 1- tetradecanol, 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) and pencillin-steptomycin were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Hydrochloric acid (HCl) was obtained from EMD 
(Gibbstown, NJ). Cetyltrimethylammonium chloride (CTAC) was obtained from TCI 
(Portland, OR, USA). Live/Dead Viability kit (Ethidium homodimer-1 and Calcein AM) and 
Trypsin-EDTA (0.25% 1X) were purchased from Life Technologies Corp. McCoy’s 5A 
medium and SKBR3 cell were purchased from  American Type Culture Collection (ATCC). 
The fromvar/carbon coated copper TEM grids were acquired from Ted Pella (Redding, CA, 
USA). Nanopure water (>18.0 MΩ-cm) was used for all experiments. 
 
Loading Dox into multifunctional nanorattles 
1 mg of Dox and 25 mg of 1-tetradecanol were added to a 5 ml scintillation vial and 
magnetically stirred at 900C. To this mixture, 100 μL of ethanol was added. Upon complete 
melting of 1-tetradecanol, pre-heated Au nanorattles solution (1 ml) at 500C was added. The 
nanorattle solution was left on the hot plate for one hour at 900C. After the evaporation of 
ethanol, 500 μL of ice cold nanopure water was added to the mixture and the vial was set 
aside to separate the Dox-loaded nanorattles. Subsequently, the nanorattles were 
resuspended in water. Nanorattles were centrifuged three times at 6000 rpm for 10 minutes 
to remove the excess DOX and 1-tetradecanol and redispersed in water. 
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Raman measurements 
As synthesized BRIGHTs and nanorattles were centrifuged two times at 10,000 rpm for 10 
minutes to remove the excess surfactant present in the solution and deposited on MPTES 
coated silicon substrate. These substrates were thoroughly rinsed with nanopure water 
before drying them under a stream of nitrogen to remove the unbound nanoparticles. The 
sparsely deposited BRIGHTs and nanorattles were identified under dark-field microscope to 
obtain SERS spectra of individual nanostructures. 
 
Cell culture 
Human epithelial breast cancer cells (SKBR3) were purchased from ATCC (Manassas, VA) 
and sub-cultured in Mc.Coy’s 5A medium with 10% fetal bovine serum (FBS) and antibiotics 
( 100 μg/ml penicillin and 100 μg/ml streptomycin) (Sigma, St. Louis, MO). Cells were 
grown in water jacket incubator at 370C with 5% CO2-humidified atmosphere in 25 cm
2 
tissue culture flasks. Once the cells reached to 90% confluence, they were washed with 
phosphate buffered saline (PBS) and detached with 1 mL of 0.25% trypsin-EDTA solution 
(Sigma). Cells were dispersed in 10 ml complete medium with 10% FBS and centrifuged. 
Cells were counted in trypan blue to confirm viability and plated at a density of 4×104 cells 
on poly(lysine) coated 0.5×0.5 cm2 silicon substrates in a flat-bottom 24-well plates (Fisher 
Scientific, Pittsburgh, PA). 
 
In vitro photothermal studies   
The NIR irradiation using a 808 nm diode laser for various durations and power densities 
(63 mW/cm2 or 260 mW/cm2) as mentioned in the text. In the case of drug release studies, 
as indicated in Figure 3.3, we used substantially low laser power density (63 mW/cm2) 
compared to combination therapy. Following laser treatment (260 mW/cm2), the cells were 
incubated with fluorescent labels of ethidium homobromide-1 and calcein AM dyes to 
produce green and red emission from live and dead cells respectively, which can be 
visualized under fluorescence microscope. 
 
In vitro SERS measurements of SKBR3 cells 
SKBR-3 cells plated on silicon substrates were rinsed two times with PBS. Then the cells 
were incubated with 1 nm nanorattles for 1 hr at 370C. The nanorattle-incubated cells were 
washed three times with DPBS to remove weakly bound or non-specifically bound 
nanoparticles and exposed to laser at 260 mW/cm2 power density for 1 min at specific 
locations. To visually identify the live and dead regions of cells, we stained the cells with 
commercially available live/dead cell viability reagent as described above. SERS spectra were 
from the dead and live cells as indicated in Figure 3.6. Raman signal is collected under 
confocal InVia Renishaw Raman microscope under bright field illumination and correlated 
with red and green fluorescence regions. 
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Experimental Section (Plasmon Enhanced Fluorescence) 
Materials 
All materials were used as received without any further purification. Polyallylamine 
Hydrochloride (MW: 56,000 g/mol) (PAH), Poly (sodium4-styrene sulfonate) (MW: 70,000 
g/mol) (PSS), 3-(mercaptopropyl) triethoxysilane (MPTES), cetyltrimethylammonium 
bromide (CTAB), gold chloride (HAuCl4.4H2O), sodium borohydride (NaBH4), ascorbic 
acid, sodium chloride (NaCl), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) and pencillin-steptomycin were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Trypsin-EDTA (0.25% 1X) was purchased from Life Technologies Corp. McCoy’s 
5A medium and SKBR3 cells were purchased from American Type Culture Collection 
(ATCC). Hydrochloric acid (HCl) was obtained from EMD (Gibbstown, NJ). 
Cetyltrimethylammoniumchloride (CTAC) was obtained from TCI (Portland, OR, USA).  
The formvar/carbon coated copper TEM grids were acquired from Ted pella (Redding, CA, 
USA). Nanopure water (>18.0 MΩ-cm) was used for all experiments.  
 
Goldnanorods adsorption on glass slides 
Glass slides (1×2 cm) were cleaned using Piranha solution (3:1 sulfuric Acid to hydrogen 
peroxide) followed by extensive rinsing with nanopure water and drying under a stream of 
dry nitrogen.  The Piranha-cleaned glass slides were exposed to 1% (3-mercaptopropyl) 
triethoxysilane in 100% pure ethanol solution for 30 minutes to render thiol functionality to 
glass slides.  The glass slides were then rinsed with ethanol and dried under a stream of 
nitrogen.   Subsequently, MPTES-functionalized glass slides were exposed to twice-
centrifuged and acidified (pH 3) gold nanoparticle/nanorods solution for 15 min.   Lowering 
the pH of the nanoparticle solution causes rapid adsorption of the nanoparticles onto thiol-
functionalized surface.  Subsequently, the glass slides were thoroughly rinsed with nanopure 
water to remove excess and weakly bound nanostructures.   A noticeable color change of the 
glass slides indicates the successful adsorption of the nanostructures.  UV-vis extinction 
spectra from glass slides exhibit distinct plasmon bands characteristic of the nanostructures 
adsorbed on the surface.    
 
Polyelectrolytes coating on slides 
We used a custom-made Teflon glass slide holder to deposit polyelectrolyte multilayers on 
glass slides.  The custom-made holder minimized the handling and consequent scratching of 
the glass surface. This experimental setup also ensures uniformity of layer-by-layer assembly 
across multiple samples, while making the coating process less tedious.   LbL was performed 
using polystyrene sulfonate (PSS) (1mM) and poly allylamine hydrochloride (PAH) (1 mM) 
in 100mM sodium chloride (NaCl) solution.   The molarity of the solutions is calculated 
from the molecular weight of the monomer unit in each polymer.  The weight to volume 
ratio for the PSS and PAH solution is 0.206 mg/mL and 0.093 mg/mL, respectively. 
Desired numbers of glass slides were placed in a Teflon holder and sequentially immersed in 
PSS, nanopure and PAH solution for 5 minutes.  The process was repeated to attain desired 
number of polyelectrolyte multilayers.   The multilayers were terminated with a PAH layer to 
adsorb the negatively charged NIR dye on the surface (Figure S22 Appendix C).  
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Polyelectrolytes coating of gold nanostructures in solution 
The nanoparticles/nanorods solution was centrifuged at 8000 rpm for 12 min, which results 
in the formation of a pellet.  The supernatant was removed and the pellet was redispersed in 
nanopure water.  The procedure was repeated twice. To 500 μL of the nanoparticle solution, 
25 μL of PSS (100 mM) was added and vortexed briefly.  To the resulting mixture, 50 μL 
NaCl (1 mM) solution was added and vortexed briefly.  The solution was subjected to 
magnetic stirring for 16-24 hours.  Subsequently, the polylectrolyte coated nanorods were 
washed by centrifugation and redispersion.  The same procedure was repeated to coat the 
nanostructures with PAH.  Desired numbers of bilayers were achieved by repeating PSS and 
PAH coating on the nanostructures.   
 
Cell culture 
Human epithelial breast cancer cells (SKBR3) were purchased from ATCC (Manassas, VA) 
and sub-cultured in Mc.Coy’s 5A medium with 10% fetal bovine serum (FBS) and antibiotics 
( 100 µg/ml penicillin and 100 µg/ml streptomycin) (Sigma, St. Louis, MO). Cells were 
grown in water jacket incubator at 370C with 5% CO2-humidified atmosphere in 25 cm
2 
tissue culture flasks. Once the cells reached to 90% confluence, they were washed with 
phosphate buffered saline (PBS) and detached with 1 mL of 0.25% trypsin-EDTA solution 
(Sigma). Cells were dispersed in 10 ml complete medium with 10% FBS and centrifuged. 
Cells were counted in trypan blue to confirm viability and plated at a density of 4×104 cells 
on poly(lysine) coated 0.5×0.5 cm2 silicon substrates in a flat-bottom 24-well plates (Fisher 
Scientific, Pittsburgh, PA). 
 
Cytotoxicity Assay (MTT)  
The cells were seeded at a density of 5 × 104 per well in a 96-well culture plate and were 
incubated overnight at 37 °C with 5% CO2. To determine the cytotoxicity of nanorattles 
with and without tetradecanol, seeded cells were incubated with the corresponding 
nanostructures for 24 hrs at 37 oC in humidified incubator with 5% CO2. To perform MTT, 
the culture medium with the nanostructures was removed and replaced with the new culture 
medium containing MTT reagents (10%) (Sigma) followed by incubation for 4 h at 37 °C, 
allowing the formation of formazan crystals. The concentration of formazan crystals was 
measured using a plate reader by recording the UV/Vis absorption maxima at 570 nm, 
which represents live cells. In the case of photothermal therapy, we repeat the MTT assay at 
different time points to estimate the percentage of nanorattle incubated cell death before 
after laser exposure (Figure 23). 
 
Fluorescence imaging 
The cells were seeded on a 5 mm wide cover glass at a density of 5 × 104 per well in a 24-
well culture plate and were incubated overnight at 370C with 5% CO2. To demonstrate the in 
vitro bioimaging of ultra-bright bullets, three different kinds of PEF probes as indicated in 
Figure 4.4 were incubated with SKBR3 cells for 4 hrs at 370C in humidified incubator with 
5% CO2 for passive targeting. Then the cells were fixed in 4% formaldehyde and washed 
three times before passivation with 1% Triton- X. Finally fixed cells were washed 3 more 
times in PBS buffer and image the cells with confocal fluorescence microscope at 785 nm 
excitation wavelength using 40X objective (Figure 6). 
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Fluorescence mapping procedure 
All fluorescence data were collected using confocal optical microscope using 785nm laser as 
excitation source.  A 2D map of the fluorescence intensity at 815 nm (in the case of LS288) 
with a 1 µm step-size is shown in Figure S13. Fluorescence map confirms the uniform 
adsorption of LS288 on polyelectrolyte multilayer-coated glass slide. 
 
Instrumentation 
Transmission electron microscopy (TEM) micrographs were recorded on a JEOL JEM-
2100F field emission (FE) instrument. Samples were prepared by drying a drop of the 
solution on a carbon-coated grid, which had been previously made hydrophilic by glow 
discharge. The excess solution on the grid was blotted away after 30 s with filter paper.  
Atomic force microscopy (AFM) was performed using Dimension 3000 (Bruker) AFM in 
light tapping mode.[38] Triangular Si cantilevers with tip radius less than 10 nm (MikroMasch) 
were employed for AFM imaging.  UV–vis extinction spectra were collected in air using a 
Shimadzu UV-1800 UV–vis spectrometer.   
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Appendix B 
Synthesis Methods 
 
Synthesis of nanostructures 
20 nm Gold nanoparticles synthesis 
Gold nanoparticles were synthesized in three steps. In the first step, seed solution was 
prepared by vigorous mixing of 5 ml of aqueous CTAC solution (0.2 M), 4.5 ml of nanopure 
water and 515 µl of HAuCl4 (4.86 mM) with 450 µl of ice-cold NaBH4
 solution. The seed 
solution was aged for 1 hr at 30oC in a hot bath. In the second step, the growth solution was 
prepared by mixing 4.5 ml of nanopure water, 5 ml of aqueous CTAC solution (0.2 M), 515 
µl of HAuCl4 (4.86 mM), and 75 µl of ascorbic acid (0.04 M). To this colorless solution, 25 µl 
of seed solution was added with vigorous stirring and kept undisturbed for two days to 
obtain highly uniform spherical nanoparticles with LSPR at 521 nm. The size of the 
nanoparticles obtained at this stage was 20 nm. 
 
Core-shell structure synthesis 
Au core-shell nanostructures were synthesized by employing 20 nm Au nanoparticles as 
cores.  Prior to adding these nanoparticles to the growth solution, the nanoparticles were 
modified with BDT. 5 µl of BDT solution (1 mM) was added to 1 ml of 20 nm core 
nanoparticles (50 nM) under vigorous sonication for 10 minutes. These modified cores were 
centrifuged twice at 12,500 rpm for 10 minutes to remove unabsorbed BDT.   Growth 
solution was prepared by mixing 862 µL of CTAC (0.1 M), 43 µL HAuCl4 (4.86 mM), and 54 
µL ascorbic acid (0.04 M).  Subsequently, 43 µL of the BDT-modified cores were added to 
growth solution, which yields ~1 mL of Au core-shell nanostructures with BDT trapped in 
between the core and shell.   
 
Core-semishell nanostructures synthesis 
For synthesis of core-semishell nanostructures, Au cores were first modified with BDT.  5 µl 
of BDT solution (1 mM) was added to 1 ml of 20 nm core nanoparticles (50 nM) under 
vigorous sonication for 10 minutes. These modified cores were centrifuged twice at 12,500 
rpm for 10 minutes to remove unabsorbed BDT.  For forming the semishell on these BDT 
modified cores they were introduced into the growth solution comprised of Au precursor, 
ascorbic acid (reductant) and CTAC (capping agent).  The growth solution was prepared by  
mixing 620 µL CTAC (0.1M), 31 µL HAuCl4 (4.86 mM), and 39 µL ascorbic acid (1.0 M) .  
310 µL of the BDT modified cores were added to this solution to yield approximately 1 mL 
core-semishell structures suspended in solution. The core-semishell structures were left 
undisturbed for three days. 
 
Au/Ag Bimetallic core-Janus shell nanostructures 
Following the synthesis of core-semishell nanostructures, exposed regions of the BDT-
modified cores was passivated with PEG to facilitate preferential growth of Ag on the 
opposite hemisphere.  For that, core-semishells were centrifuged two times at 8000 rpm to 
completely remove the free CTAC from the reaction and dispersed with SH-PEG solution 
(10 µM). The resultant solution was sonicated for 30 minutes and left on natauting mixer for 
12 hours. Silver growth solution was prepared by mixing of 620 µL of CTAC (0.1 M), 31 µL 
of AgNO3 solution (4.86 mM), and 39 µL of ascorbic acid (1.0 M).  We then added 310 µL 
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of the PEG-passivated core-semishell nanostructures to form core-Janus shell 
nanostructures. 
 
Au/Ag Bimetallic Core/Shell nanostructures 
Following the synthesis of core-semishell structures as described above, the nanostructures 
were centrifuged and resuspended in 0.9 mM polyvinylpyrrolidone (PVP) solution followed 
by ultrasonication for 3-5 min.  Silver growth solution was prepared by mixing 567 µL of 
CTAC (0.1M), 113 µL of AgNO3 solution (4.86 mM), and 35 µL of ascorbic acid (1.0 M).  
We then added 283 µL of core-semishell structures to the silver growth solution.  The 
particles were left undisturbed for 2-4 days. 
 
Synthesis of multifunctional Au nanorattles 
Au nanorattles were synthesized in a multistep process involving the synthesis of BRIGHTs, 
as described previously, followed by the formation of a porous Au shell around them. 
Briefly, BRIGHTs were synthesized using a method similar to seed-mediated growth, except 
that the cores serve as seeds in this case. 5 μl of BDT solution (1 mM) was added to 1 ml of 
20 nm core nanoparticles (50 nM) under vigorous sonication for 10 minutes. These modified 
cores were centrifuged twice at 12,500 rpm for 10 minutes to remove unabsorbed BDT. A 
20 nm thick gold shell was grown on BDT-modified cores by adding 1 ml CTAC (0.1 M), 50 
μl of ascorbic acid (1 M), 50 μl of HAuCl4 (4.86 mM) to 50 μl of BDT-modified core 
nanoparticle solution. 
 
Following the synthesis of BRIGHTs, a silver shell was grown around these nanostructures, 
which was subsequently transformed into a porous gold shell using galvanic replacement 
reaction. For forming a silver shell on BRIGHTs, polyvinylpyrrolidone (PVP) was employed 
as the stabilizing agent. BRIGHTs were modified with PVP by suspending the 
nanostructures in 0.9 mM polyvinylpyrrolidone (PVP) solution followed by brief sonication 
for 3-5 minutes. Subsequently, 7.5 μL of PVP (90 mM), and 84.6 μL of ascorbic acid (1.0 M) 
were added to 671 μL of PVP-modified BRIGHTs. 237 μL of silver nitrate (AgNO3) 
solution (4.86 mM) was added to the above mixture and stirred vigorously for 10 seconds. 
The reaction solution was left undisturbed for three to four days to allow the formation of 
Ag@BRIGHT nanostructures. 
 
Galvanic replacement reaction was employed to transform the silver shell of Ag@BRIGHT 
into a porous gold shell. The Ag@BRIGHTs solution was centrifuged for 10 minutes at 
8,000 rpm and resuspended in 1 mM PVP solution. 2 mL of the PVP-modified 
Ag BRIGHTs solution was brought to boil by heating at 100  C. HAuCl4 (1 mM) solution 
was added to the Ag@BRIGHTs at a rate of 500 μL/minute, while constantly stirring the 
solution. Addition of gold salt was stopped once the solution turned to vibrant blue/purple 
color. The volume of HAuCl4 added was approximately 1.4 mL. However, the exact volume 
of the solution is determined by the thickness of Ag shell. 
 
Synthesis of shape-controlled gold nanostructures  
Various shape-controlled gold nanostructures were synthesized using seed-mediated 
approach reported in literature with small modifications.  Gold nanorods were synthesized 
using a seed-mediated approach. Seed solution was prepared by adding 0.6 ml of an ice-cold 
sodium borohydride solution (10 mM) into 10 ml of 0.1 M cetyltrimethylammonium 
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bromide (CTAB) and 2.5 × 10-4 M chloroauric acid (HAuCl4) solution under vigorous 
stirring at room temperature. The color of the seed solution changed from yellow to brown. 
Growth solution was prepared by mixing 95 ml of CTAB (0.1 M), 0.5 ml of silver nitrate (10 
mM), 4.5 ml of HAuCl4 (10 mM), and 0.55 ml of ascorbic acid (0.1 M) consecutively. The 
solution was homogenized by gentle stirring. To the resulting colorless solution, 0.12 ml of 
freshly prepared seed solution was added and set aside in the dark for 14 h prior to use, the 
AuNR solution was centrifuged twice at 10,000 rpm for 10 min to remove excess CTAB and 
redispersed in nanopure water (18.2 MΩ-cm).  Details of other nanostructures synthesis are 
provided in the supporting information. 
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Appendix C 
Supporting Information 
 
 
Figure S1 - UV/Vis extinction spectra of Ag@BRIGHT core/shell 
nanostructures at different time points of Ag growth on BRIGHTs. 
The thickness of the silver is crucial to tune optical properties of 
nanorattle. 
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Figure S2 - Ag@BRIGHTs solution in a 200 ml bottle demonstrating the 
feasibility of large scale synthesis of the nanostructures and the solutions in 
centrifuge tubes exhibit the color of BRIGHTs, Ag@BRIGHTs, and nanorattles. 
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Figure S4 - UV/Vis extinction spectra of different sizes of nanorattles. The 
thickness of the porous shell leads to significant change in absorption in NIR 
region as shown above.  
 
Figure S3 - Uv/Vis extinction spectra of nanorattles before and after loading 
phase change material, 1-tetradecanol, to contain or release the doxorubicin upon 
laser irradiation. 
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Figure S5 - TEM image of 1-tetradeconol + Dox loaded nanorattles. 
Stage 1 Stage 2
Stage 3 Stage 4+Drug
Figure S6 - TEM images of Nanorattles at different stages of Galvanic 
replacement of Ag@BRIGHTs 
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Figure S7 - Time-dependant  doxorubicin release from nanorattle at 50 oC 
and 37 oC depicting the progressive release of Dox at 50°C and absence of 
release at  37 oC. 
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Figure S8 - Serum stability of nanorattles in (left) different percentages of 
FBS and (right) at different time points in 10 % FBS. 
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Figure S9 - Cell viability as probed by MTT assay at different laser exposure times 
with a power density of  63.4 mW/cm2 in the presence of 1 ng/ml nanorattles. 
 
Figure S10 - Cell viability as determined by MTT assay for different 
concentrations of nanorattles loaded with 1-tetradeconol after laser irradiation 
with a power density of 63.4 mW/cm2 for 30 sec.  
 
Figure S111 - Cell viability as determined by MTT assay at different laser power 
densities in the presence of 1ng/mL nanorattles loaded with 1-tetradecanol 
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Figure S12 . Transmission electron microscopy images of sectioned SKBR3 cell 
before and after photothermal therapy. The inset in figure B clearly shows the 
ruptured nanorattles after photothermal therapy. 
 
Figure 13 - In vitro fluorescence images of SKBR3 cells after incubation with Dox 
loaded Nanorattles in the absence of laser exposure. 
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Figure S 14.Raman scattering spectrum of 1,4-benzenedithiol powder. 
Figure S 15 – Raman scattering spectrum of 2-naphthalenethiol powder. 
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Figure S 15 - Raman scattering spectrum of doxorubicin powder. 
Figure S 16 - Raman scattering spectrum of 1-tetradecanol 
powder. 
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Figure S 18 - Different steps involved in the synthesis of 
LS288. 
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Figure S 19 - Vis-NIR extinction spectra obtained from (i) MPTES 
coated blank glass slides (ii) Dye adsorbed on PAH (iii) AuNR 
coated with two bilayers and (iv) AuNR coated with two bilayers 
followed by dye adsorption.   
 
Figure S 20 - Vis-NIR extinction spectra of three different dyes: 
LS288, Cypate and Cypate-3 
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Figure S 21 - Vis-NIR extinction spectra of AuNR coated glass slides with varying number of 
polyelectrolyte layers compared to the peak position of the LS288 and Cypate 3 dyes 
 
Figure S 22 - Vis-NIR extinction spectra of AuNR with PEMs after each bilayer coating. 
Normalized extinction spectra exhibit progressive red-shift after every bilayer due to the 
increase in local refractive index with polyelectrolyte coating. 
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Figure S 23 - AFM analysis of gold nanorods adsorbed glass slide coated with 20 layers of 
PEMs. 
 
Figure S 24 - Vis-NIR extinction spectra of AuNR with 0 layers and 12 layers compared with 
the absorption spectrum of LS288.  After the deposition of 12 layers of polyelectrolytes on 
AuNR the LSPR of AuNR matches with the absorption of the dye.  However, the increased 
distance from the surface of AuNR results in smaller (nearly 5 times) PEF compared to the 
best case (i.e., 4 layers separation and LSPR match with absorption). 
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Figure S 25 - Vis-NIR extinction spectra of a control dye Cypate-3 adsorbed on AuNR. 
Although the LSPR of AuNRs matches with the laser excitation, no fluorescence was 
observed due to the mismatched absorption maximum of the dye. This indicates the 
importance of the overlap of the dye absorption with LSPR of the nanostructures. 
Figure S 26 - PEF of dye adsorbed on AuNR of different aspect ratio. The maximum PEF 
was obtained in the case of NRs-790 due to strong overlap of the LSPR of AuNR and 
absorption of the dye. 
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Figure S 27 - Fluorescence spectra of LS288 adsorbed on AuNR of different aspect ratio. The 
LSPR wavelength of AuNR is indicated in the plot. 
 
Figure S 28 - Vis-NIR extinction spectra of AuNR-4.5, AuNR-2.3, and AuNR-1 in solution 
before (left) and after (right) polyelectrolyte coating. 
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Figure S 29 - Scanning electron microscope (SEM) image of as synthesized AuNRs prior to 
polyelectrolyte coating. 
 
Figure S 30 - Scanning electron microscope (SEM) image of as synthesized AuNRs prior to 
polyelectrolyte coating. 
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Figure S 31 - Fluorescence mapping of LS288 on PAH coated glass slide. 
 
Table S 1 - Size distribution of the nanorods and nanoparticle used in this article. 
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Figure S 32 - (A) Absorption spectrum of Eosin Y (Inset) and extinction properties of GNPs 
adsorbed on glass slide. (B) Extinction spectra of GNPs obtained after the deposition of “n” 
bilayers indicated in the plot. (C) Progressive red shift after polyelectrolyte layers on GNPs 
confirms the successful deposition of polyelectrolytes. (D) Plot depicting the increase in 
fluorescence intensity with increasing spacing between the Eosin Y and GNPs. 
Figure S 33 - Plot depicting the LSPR shift after deposition of polyelectrolyte layers on GNPs 
deposited glass slide. 
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Figure S 34 - Atomic Force Microscopy is employed to measure the thickness of 
polyelectrolyte layers after 12 layers on GNPs deposited glass slide. We confirmed that the 
average thickness of each layer is ~ 1 nm. 
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